332 related articles for article (PubMed ID: 19481811)
1. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography.
Yokoi T; Hiraoka M; Miyamoto M; Yokoi T; Kobayashi Y; Nishina S; Azuma N
Ophthalmology; 2009 Jul; 116(7):1377-82. PubMed ID: 19481811
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of scleral buckling for stage 4A retinopathy of prematurity by fluorescein angiography.
Yokoi T; Yokoi T; Kobayashi Y; Hiraoka M; Nishina S; Azuma N
Am J Ophthalmol; 2009 Oct; 148(4):544-550.e1. PubMed ID: 19589496
[TBL] [Abstract][Full Text] [Related]
3. Effect of early vitreous surgery for aggressive posterior retinopathy of prematurity detected by fundus fluorescein angiography.
Nishina S; Yokoi T; Yokoi T; Kobayashi Y; Hiraoka M; Azuma N
Ophthalmology; 2009 Dec; 116(12):2442-7. PubMed ID: 19818508
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for recurrent fibrovascular proliferation in aggressive posterior retinopathy of prematurity after early vitreous surgery.
Yokoi T; Yokoi T; Kobayashi Y; Nishina S; Azuma N
Am J Ophthalmol; 2010 Jul; 150(1):10-15.e1. PubMed ID: 20609704
[TBL] [Abstract][Full Text] [Related]
5. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity.
Lepore D; Molle F; Pagliara MM; Baldascino A; Angora C; Sammartino M; Quinn GE
Ophthalmology; 2011 Jan; 118(1):168-75. PubMed ID: 20709401
[TBL] [Abstract][Full Text] [Related]
6. A small foveal avascular zone may be an historic mark of prematurity.
Mintz-Hittner HA; Knight-Nanan DM; Satriano DR; Kretzer FL
Ophthalmology; 1999 Jul; 106(7):1409-13. PubMed ID: 10406630
[TBL] [Abstract][Full Text] [Related]
7. Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease.
Flynn JT; Chan-Ling T
Am J Ophthalmol; 2006 Jul; 142(1):46-59. PubMed ID: 16815250
[TBL] [Abstract][Full Text] [Related]
8. The rate of retinal vessel dilation in severe retinopathy of prematurity requiring treatment.
Grunwald L; Mills MD; Johnson KS; Karp KA; Quinn GE; Ying GS; Grunwald JE
Am J Ophthalmol; 2009 Jun; 147(6):1086-91, 1091.e1-2. PubMed ID: 19286152
[TBL] [Abstract][Full Text] [Related]
9. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy.
Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
J AAPOS; 2014 Apr; 18(2):120-3. PubMed ID: 24698606
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography findings in stage 4A retinopathy of prematurity: a theory for visual variability.
Joshi MM; Trese MT; Capone A
Ophthalmology; 2006 Apr; 113(4):657-60. PubMed ID: 16581425
[TBL] [Abstract][Full Text] [Related]
12. Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).
Wutthiworawong B; Thitiratsanont U; Saovaprut C; Subhangkasen I; Geyuraphun B; Ampornprut A; Phumongkutchai J; Tephusdinnaayuthaya S
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S15-21. PubMed ID: 22043749
[TBL] [Abstract][Full Text] [Related]
13. Management of avascular peripheral retina in older prematurely born infants.
Ho LY; Ho V; Aggarwal H; Ranchod TM; Capone A; Trese MT; Drenser KA
Retina; 2011; 31(7):1248-54. PubMed ID: 21358456
[TBL] [Abstract][Full Text] [Related]
14. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity.
Liu K; Akula JD; Falk C; Hansen RM; Fulton AB
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2639-47. PubMed ID: 16723481
[TBL] [Abstract][Full Text] [Related]
15. The photographic screening for retinopathy of prematurity study (photo-ROP). Primary outcomes.
Photographic Screening for Retinopathy of Prematurity (Photo-ROP) Cooperative Group
Retina; 2008 Mar; 28(3 Suppl):S47-54. PubMed ID: 18317345
[TBL] [Abstract][Full Text] [Related]
16. A hybrid form of retinopathy of prematurity.
Sanghi G; Dogra MR; Dogra M; Katoch D; Gupta A
Br J Ophthalmol; 2012 Apr; 96(4):519-22. PubMed ID: 22096143
[TBL] [Abstract][Full Text] [Related]
17. Progression and timing of treatment of zone I retinopathy of prematurity.
Soh Y; Fujino T; Hatsukawa Y
Am J Ophthalmol; 2008 Sep; 146(3):369-374. PubMed ID: 18602081
[TBL] [Abstract][Full Text] [Related]
18. Fluorescein angiography and retinal vascular development in premature infants.
Purcaro V; Baldascino A; Papacci P; Giannantonio C; Molisso A; Molle F; Lepore D; Romagnoli C
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():53-6. PubMed ID: 23016619
[TBL] [Abstract][Full Text] [Related]
19. RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY: A Longitudinal Fluorescein Angiographic Study.
Lorenz B; Stieger K; Jäger M; Mais C; Stieger S; Andrassi-Darida M
Retina; 2017 Jan; 37(1):97-111. PubMed ID: 27454223
[TBL] [Abstract][Full Text] [Related]
20. Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.
Kychenthal A; Dorta P; Katz X
Retina; 2006 Sep; 26(7 Suppl):S11-5. PubMed ID: 16946670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
